Disulfiram: A Clinically Proven Aid for Alcohol Dependence Management
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.22 (0%) | 🛒 Add to cart |
| 60 | $1.11 | $82.43 $66.35 (20%) | 🛒 Add to cart |
| 90 | $1.02 | $123.65 $91.48 (26%) | 🛒 Add to cart |
| 120 | $0.98 | $164.87 $117.62 (29%) | 🛒 Add to cart |
| 180 | $0.94 | $247.30 $168.89 (32%) | 🛒 Add to cart |
| 270 | $0.90 | $370.96 $244.29 (34%) | 🛒 Add to cart |
| 360 | $0.89
Best per pill | $494.61 $318.68 (36%) | 🛒 Add to cart |
Synonyms | |||
Disulfiram is a well-established pharmacological agent indicated as an adjunct in the comprehensive management of chronic alcohol dependence. It functions as an alcohol-sensitizing agent, producing a highly unpleasant physiological reaction when alcohol is consumed, thereby serving as a powerful psychological deterrent. This aversive therapy is designed to support motivated patients within a structured treatment program that includes counseling and psychosocial support. Its efficacy is contingent upon full patient understanding, informed consent, and a firm commitment to abstinence.
Features
- Active Ingredient: Disulfiram.
- Mechanism of Action: Irreversible inhibitor of the enzyme aldehyde dehydrogenase (ALDH).
- Administration: Oral tablet.
- Standard Tablet Strengths: 250 mg and 500 mg.
- Onset of Action: The sensitization to alcohol begins within 12 hours of ingestion and is fully effective approximately 1-2 hours after a dose.
- Duration of Effect: The aversive effect can persist for up to 14 days following the last dose due to the irreversible nature of enzyme inhibition, requiring the body to synthesize new ALDH.
- Bioavailability: Readily absorbed from the gastrointestinal tract, with peak plasma concentrations reached within a few hours. Metabolized primarily in the liver and excreted slowly.
Benefits
- Creates a Powerful Psychological Deterrent: The certainty of a severe adverse reaction provides a strong external motivator to resist alcohol consumption, helping patients break habitual drinking patterns.
- Supports Long-Term Abstinence Goals: By providing a consistent chemical barrier to drinking, it allows patients time to engage with and benefit from behavioral therapies and build new, healthier coping mechanisms.
- Reinforces Patient Accountability: The daily act of taking the medication, often supervised, serves as a daily recommitment to the treatment plan and reinforces the patient’s decision to remain sober.
- Facilitates Structured Recovery: It is a tangible component of a multi-faceted treatment program, providing a clear framework for both the patient and the healthcare provider to monitor progress.
- Empowers Patient Control: For motivated individuals, it offers a tool to regain control over alcohol use, reducing the anxiety associated with the potential for impulsive drinking.
Common use
Disulfiram is used as a deterrent therapy in the management of selected patients with chronic alcohol dependence who want to remain in a state of enforced sobrience. Its use is predicated on the patient’s explicit desire to maintain abstinence and their full comprehension of the consequences of alcohol consumption while on the drug. It is never intended as a standalone treatment but is most effective when integrated into a complete recovery program that includes medical supervision, psychological support, counseling, and participation in support groups like Alcoholics Anonymous (AA). It is typically prescribed after a patient has undergone detoxification and has achieved initial abstinence.
Dosage and direction
Administration must be initiated only when the patient has abstained from alcohol for at least 12 hours and is in a state of relative sobriety. A preliminary test for alcohol in the breath or blood is recommended.
- Initial Dosage: The maximum recommended initial dose is 500 mg daily (as a single dose or in divided doses) for one to two weeks.
- Maintenance Dosage: The usual maintenance dose is 250 mg daily (range: 125 mg to 500 mg). The dosage may be adjusted downward based on patient response and the emergence of side effects.
- Timing: The tablet should be taken in the morning, as the temptation to drink may be greater in the evening. It can be taken with food or water to minimize gastric upset.
- Duration of Therapy: The duration of treatment is highly individualized and may continue for months or even years, provided it remains therapeutically effective and no unacceptable adverse effects occur. The decision to discontinue should be made collaboratively with the prescribing physician.
- Supervised Administration: To ensure compliance, administration by a family member, healthcare professional, or within a clinic setting is often advised.
Precautions
- Informed Consent: The patient must be fully informed, comprehend, and willingly accept the risks associated with the disulfiram-ethanol reaction (DER). Written consent is often obtained.
- Liver Function Monitoring: Baseline liver function tests (LFTs) must be performed before initiation of therapy and at regular intervals thereafter (e.g., every 2-4 weeks for the first 3-6 months, then periodically) due to the risk of hepatotoxicity, including potentially fatal hepatitis.
- Psychiatric History: Use with caution in patients with a history of psychosis, diabetes mellitus, hypothyroidism, epilepsy, cerebral damage, or renal impairment.
- Hidden Alcohol Sources: Patients must be counseled to avoid all sources of alcohol, including:
- Medicinal preparations: Cough syrups, elixirs, tonics, and some mouthwashes.
- Food products: Vinegars, sauces (e.g., wine vinegar, soy sauce), desserts containing alcohol, and even overripe fruit.
- Topical products: Aftershaves, perfumes, colognes, liniments, and some solvents.
- Pregnancy and Lactation: Disulfiram is contraindicated in pregnancy. It is not recommended for use in nursing mothers as it is excreted in breast milk.
Contraindications
Disulfiram therapy is absolutely contraindicated in the presence of:
- Severe myocardial disease or coronary occlusion.
- Psychosis (current or severe history).
- Hypersensitivity to disulfiram or other thiuram derivatives used in pesticides and rubber vulcanization.
- Pregnancy.
- Concurrent use of alcohol or alcohol-containing products.
- Concurrent use of metronidazole, paraldehyde, or certain other drugs (see Drug Interactions).
Possible side effect
Common:
- Drowsiness, fatigue, headache, metallic or garlic-like aftertaste (especially during the first two weeks of therapy).
- Acneiform eruptions, allergic dermatitis.
Less Common / Potentially Serious:
- Hepatotoxicity: From transient transaminase elevations to hepatitis, cholestasis, and hepatic failure. Symptoms include malaise, anorexia, nausea, vomiting, abdominal pain, jaundice, and dark urine.
- Peripheral Neuropathy: Numbness, tingling, or pain in the hands and feet. May be irreversible if not caught early.
- Optical Neuritis: Blurred vision, eye pain.
- Psychiatric Effects: Psychotic reactions, mood changes, confusion, memory impairment.
- Polyneuritis.
Any new neurological or psychiatric symptom, or signs of hepatitis, warrants immediate medical evaluation and likely discontinuation of the drug.
Drug interaction
Disulfiram inhibits several hepatic microsomal enzymes, leading to significant interactions:
- Warfarin: Potentiates anticoagulant effect, increasing prothrombin time and risk of bleeding. Warfarin dosage must be reduced and monitored closely.
- Phenytoin: Increases phenytoin serum levels, leading to potential phenytoin toxicity (ataxia, nystagmus, lethargy). Monitor phenytoin levels.
- Benzodiazepines (e.g., diazepam, chlordiazepoxide): May increase sedative effects and prolong half-life.
- Tricyclic Antidepressants: Metabolism may be inhibited.
- Isoniazid: Increased risk of adverse CNS effects, such as dizziness and unsteady gait.
- Theophylline: Inhibits metabolism, potentially leading to theophylline toxicity.
- Metronidazole: Concomitant use may cause confusion and psychotic reactions; is contraindicated.
Missed dose
- If a dose is missed, it should be taken as soon as remembered on the same day.
- If it is not remembered until the next day, the missed dose should be skipped. The patient should not double the dose to make up for the missed one.
- Consistent daily dosing is critical for maintaining the aversive barrier. Patients should inform their physician or support person of any missed doses.
Overdose
Symptoms: Overdose can be severe and may include nausea, vomiting, GI upset, dizziness, ataxia, lethargy, seizures, and neurological complications. In massive overdose, the primary concerns are neurological depression and cardiovascular collapse. Management: There is no specific antidote for disulfiram overdose. Management is supportive and symptomatic. Gastric lavage may be considered if ingestion is recent. Activated charcoal can be administered. Close monitoring of vital signs, electrolytes, and neurological status is essential. Support respiratory and cardiovascular function as needed.
Storage
- Store at controlled room temperature (20°C to 25°C or 68°F to 77°F).
- Protect from light and moisture. Keep the bottle tightly closed.
- Keep out of reach of children and pets.
- Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided has been compiled from medical literature but may not be exhaustive or reflect the most recent developments.
Reviews
- “As a psychiatrist specializing in addiction, disulfiram is a cornerstone tool for a specific subset of my patients. Its effectiveness is 100% dependent on patient motivation and a robust support system. When used correctly, it can be a literal lifesaver, providing the concrete barrier a patient needs to build a foundation for recovery.” – Dr. A., MD, Psychiatry
- “I’ve been sober for 18 months, and I credit disulfiram for getting me through the first critical year. Knowing the reaction was waiting for me took the ‘maybe just one’ thought completely off the table. It gave me the space to actually work on my recovery in therapy.” – Patient J.C.
- “The monitoring requirements are significant, but necessary. The risk of hepatotoxicity is real, which is why we insist on regular blood work. For the right patient, the benefits of sustained abstinence far outweigh the risks, which are manageable with vigilant oversight.” – Clinical Pharmacist, Addiction Clinic
- “It didn’t work for me because I wasn’t truly ready to stop. I stopped taking it so I could drink. This medication isn’t magic; you have to want it to work. It’s a tool, not a cure.” – Patient Anonymous